An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Li, MuLan ^a   Song, Yonghyun ^b   Cho, Nariya ^a   Chang, Jung Min ^a   Koo, Hye Ryoung ^a   Yi, Ann ^a   Kim, Hyeonjin ^a   Park, Sunghyouk ^b   Moon, Woo Kyung ^a  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CONTROLLED STUDY; FEMALE; HIGH RESOLUTION MAGIC SPINNING ANGLE MAGNETIC RESONANCE SPECTROSCOPY; HUMAN; HUMAN TISSUE; METABOLOMICS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; BREAST; BREAST TUMOR; CYTOLOGY; DISCRIMINANT ANALYSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS;

ADULT; AGED; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80054765285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025563     Document Type: Article

References (36)

1. Wen H, Yoo SS, Kang J, Kim HG, Park JS, et al. (2010) A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J Hepatol 52: 228-233.
2. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8: 1439-1444.
3. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, et al. (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440: 1073-1077.
4. Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TM, et al. (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 5: 1019-1032.
5. Martinez-Granados B, Morales JM, Rodrigo JM, Del Olmo J, Serra MA, et al. (2011) Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies. Int J Mol Med 27: 111-117.
6. Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Humpfer E, et al. (2010) Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 9: 319-332.
7. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, et al. (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8: 352-361.
8. Burns MA, He W, Wu CL, Cheng LL, (2004) Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics. Technol Cancer Res Treat 3: 591-598.
9. DeFeo EM, Cheng LL, (2010) Characterizing human cancer metabolomics with ex vivo 1H HRMAS MRS. Technol Cancer Res Treat 9: 381-391.
10. Bathen TF, Sitter B, Sjobakk TE, Tessem MB, Gribbestad IS, (2010) Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation. Cancer Res 70: 6692-6696.
11. Sitter B, Bathen TF, Singstad TE, Fjosne HE, Lundgren S, et al. (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 23: 424-431.
12. Giskeødegård GF, Grinde MT, Sitter B, Axelson DE, Lundgren S, et al. (2010) Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics. J Proteome Res 9: 972-979.
13. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, et al. (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19: 30-40.
14. Cheng LL, Chang IW, Smith BL, Gonzalez RG, (1998) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 135: 194-202.
15. Mountford CE, Somorjai RL, Malycha P, Gluch L, Lean C, et al. (2001) Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 88: 1234-1240.
16. Bathen TF, Jensen LR, Sitter B, Fjosne HE, Halgunset J, et al. (2007) MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 104: 181-189.
17. Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, et al. (2008) Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models. Anal Chem 80: 115-122.
18. Bylesjo M, Rantalainen M, Cloarec O, Nicholson J, Holmes E, et al. (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom 20: 341-351.
19. Sands CJ, Coen M, Maher AD, Ebbels TM, Holmes E, et al. (2009) Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery. Anal Chem 81: 6458-6466.
20. Holmes E, Cloarec O, Nicholson JK, (2006) Probing latent biomarker signatures and in vivo pathway activity in experimental disease states via statistical total correlation spectroscopy (STOCSY) of biofluids: application to HgCl2 toxicity. J Proteome Res 5: 1313-1320.
21. Kang J, Choi MY, Kang S, Kwon HN, Wen H, et al. (2008) Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines. J Agric Food Chem 56: 11589-11595.
22. Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK, (2009) Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 106: 14728-14733.
23. Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS, (2002) High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15: 327-337.
24. Li M, Wang B, Zhang M, Rantalainen M, Wang S, et al. (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105: 2117-2122.
25. Kwon HN, Kim M, Wen H, Kang S, Yang HJ, et al. (2011) Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. Kidney Int 79: 529-537.
26. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D, (1999) Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19: 1737-1746.
27. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE, (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiol 209: 269-275.
28. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE, (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68: 45-54.
29. Negendank W, (1992) Studies of human tumors by MRS: a review. NMR Biomed 5: 303-324.
30. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H, (2002) Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62: 1966-1970.
31. Singer S, Souza K, Thilly WG, (1995) Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study. Cancer Res 55: 5140-5145.
32. Ting YL, Sherr D, Degani H, (1996) Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 16: 1381-1388.
33. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, et al. (2003) Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 50: 944-954.
34. Beckonert O, Monnerjahn J, Bonk U, Leibfritz D, (2003) Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed 16: 1-11.
35. Larsen TO, Smedsgaard J, Nielsen KF, Hansen ME, Frisvad JC, (2005) Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Nat Prod Rep 22: 672-695.
36. Thomas MA, Lipnick S, Velan SS, Liu X, Banakar S, et al. (2009) Investigation of breast cancer using two-dimensional MRS. NMR Biomed 22: 77-91.